CD40LG and COVID-19: Since both IgM and IgA have been shown to appear in the first 3 to 4 days of SARS-CoV-2 infection (25), our hypothesis is that we identified patients in the very early phase of COVID-19, before they developed symptoms or even seroconverted to IgG.